Correlation Between RYOHIN UNSPADR/1 and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both RYOHIN UNSPADR/1 and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RYOHIN UNSPADR/1 and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RYOHIN UNSPADR1 and Takeda Pharmaceutical, you can compare the effects of market volatilities on RYOHIN UNSPADR/1 and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RYOHIN UNSPADR/1 with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of RYOHIN UNSPADR/1 and Takeda Pharmaceutical.
Diversification Opportunities for RYOHIN UNSPADR/1 and Takeda Pharmaceutical
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between RYOHIN and Takeda is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding RYOHIN UNSPADR1 and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and RYOHIN UNSPADR/1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RYOHIN UNSPADR1 are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of RYOHIN UNSPADR/1 i.e., RYOHIN UNSPADR/1 and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between RYOHIN UNSPADR/1 and Takeda Pharmaceutical
Assuming the 90 days trading horizon RYOHIN UNSPADR1 is expected to generate 1.49 times more return on investment than Takeda Pharmaceutical. However, RYOHIN UNSPADR/1 is 1.49 times more volatile than Takeda Pharmaceutical. It trades about 0.09 of its potential returns per unit of risk. Takeda Pharmaceutical is currently generating about 0.12 per unit of risk. If you would invest 2,160 in RYOHIN UNSPADR1 on December 29, 2024 and sell it today you would earn a total of 220.00 from holding RYOHIN UNSPADR1 or generate 10.19% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.44% |
Values | Daily Returns |
RYOHIN UNSPADR1 vs. Takeda Pharmaceutical
Performance |
Timeline |
RYOHIN UNSPADR/1 |
Takeda Pharmaceutical |
RYOHIN UNSPADR/1 and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RYOHIN UNSPADR/1 and Takeda Pharmaceutical
The main advantage of trading using opposite RYOHIN UNSPADR/1 and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RYOHIN UNSPADR/1 position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.RYOHIN UNSPADR/1 vs. CORNISH METALS INC | RYOHIN UNSPADR/1 vs. STMICROELECTRONICS | RYOHIN UNSPADR/1 vs. East Africa Metals | RYOHIN UNSPADR/1 vs. Jacquet Metal Service |
Takeda Pharmaceutical vs. CVW CLEANTECH INC | Takeda Pharmaceutical vs. Tower Semiconductor | Takeda Pharmaceutical vs. MELIA HOTELS | Takeda Pharmaceutical vs. BE Semiconductor Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |